Projects per year
Fingerprint Dive into the research topics where Richard Turkington is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 49 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 1 Active
Research Output
Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study
McCain, R. S., McManus, D. T., McQuaid, S., James, J. A., Salto-Tellez, M., Reid, N. B., Craig, S., Chisambo, C., Bingham, V., McCarron, E., Parkes, E., Turkington, R. C. & Coleman, H. G., 01 Jan 2020, In : Cancer Causes and Control. 31, 1, p. 1-11Research output: Contribution to journal › Article
Open Access
File
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma
Thomas, A., Virdee, P. S., Eatock, M., Lord, S. R., Falk, S., Anthoney, D. A., Turkington, R. C., Goff, M., Elhussein, L., Collins, L., Love, S., Moschandreas, J. & Middleton, M. R., Jan 2020, In : European Journal of Cancer. 124, p. 131-141 11 p.Research output: Contribution to journal › Article
Open Access
File
Machine learning to predict early recurrence after oesophageal cancer surgery
on behalf of the OCCAMS Consortium, 30 Jan 2020, In : British Journal of Surgery.Research output: Contribution to journal › Article
Open Access
File
Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
the OCCAMS consortium, 22 Jan 2019, In : Scientific Reports. 9, 318.Research output: Contribution to journal › Comment/debate
Open Access
File
External validation of a model to determine risk of progression of Barrett’s oesophagus to neoplasia
Kunzmann, A. T., Thrift, A. P., Johnston, B. T., McManus, D. T., Gavin, A. T., Turkington, R. C. & Coleman, H. G., 01 May 2019, In : Alimentary Pharmacology and Therapeutics. 49, 10, p. 1274-1281Research output: Contribution to journal › Article
Open Access
File
2
Citations
(Scopus)
4
Downloads
(Pure)
Activities
OGCancer NI cheque presentation for funding to support ICHOR study
Richard Turkington (Recipient)
09 Nov 2020
Activity: Other activity types › Other
Pharmaceuticals (Basel) (Journal)
Richard Turkington (Peer reviewer)
23 Jan 2019
Activity: Publication peer-review and editorial work types › Publication peer-review
Launch of OGCancer NI 'Catch it Early' Campaign
Richard Turkington (Speaker)
06 Jun 2019
Activity: Talk or presentation types › Invited talk
CALIBRATION clinical trial: Member of Trial Steering Committee
Richard Turkington (Recipient)
15 May 2019 → …
Activity: Other activity types › Other
Foundation Doctors Academic Conference
Richard Turkington (Participant)
17 May 2019
Activity: Participating in or organising an event types › Participation in conference
Press / Media
Thesis
Epidemiological risk factors, related biomarkers and oesophageal adenocarcinoma survival
Author: McCain, S., Jul 2020Supervisor: Coleman, H. (Supervisor) & Turkington, R. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Philosophy
Molecular Biology of AKT Inhibition in Gastro-oesophageal Adenocarcinoma
Author: Cairns, L., Jul 2019Supervisor: Turkington, R. (Supervisor), Kennedy, R. (Supervisor) & Harrison, T. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Philosophy